← FDA Drug Approvals (Drugs@FDA)

TOBRAMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MICRO LABS · Approved 2023-07-27

Drug application

FDA Application #

ANDA217344

Application type

Abbreviated New Drug Application (Generic)

Brand name

TOBRAMYCIN

Generic name

TOBRAMYCIN SOLUTION

Active ingredients

TOBRAMYCIN

Dosage form

SOLUTION

Route

INHALATION

Marketing status

Prescription

Sponsor

MICRO LABS

Manufacturer

Micro Labs Limited

First approval

2023-07-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown